81517 Liver ds alys 3 bmrk srm alg
Also known as: liver disease panel, hepatic fibrosis assessment
Liver disease analysis using three biomarkers in serum with algorithm.
In Plain Language
blood test for liver disease
Clinical Context
Serological biomarker panel for assessment of liver disease severity and fibrosis progression (e.g., FIB-4, APRI scores).
RVU Information
CPT 81517 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81517?
CPT 81517 (Liver ds alys 3 bmrk srm alg) is a Pathology & Lab code. Liver disease analysis using three biomarkers in serum with algorithm.
Who uses CPT code 81517?
CPT 81517 is used by hepatology, pathology, molecular pathology. Serological biomarker panel for assessment of liver disease severity and fibrosis progression (e.g., FIB-4, APRI scores).
When is CPT 81517 used?
Serological biomarker panel for assessment of liver disease severity and fibrosis progression (e.g., FIB-4, APRI scores).
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.